Recent data suggest that the protection against ischemic heart disease afforded by high density lipoprotein (HDL) cholesterol (C) may be concentrated in the HDL 2 subfraction. To examine the behavioral correlates of the HDL subfractions, we recalled 33 men and 17 women of a random sample from the Pacific Northwest Bell Telephone Company Health Survey. Adiposity and very low density lipoprotein (VLDL) triglyceride were negatively correlated with HDL 2 C. Smoking was not correlated with HDL 2 C, but was negatively correlated with HDL 3 C (men, r s = -0.635, p = 0.001; women, r s = -0.534, p -0.014); this relationship was independent of alcohol consumption, adiposity, and VLDL triglyceride. Alcohol consumption was also more strongly related to HDL 3 C (men, r s = 0.248, p = 0.082; women, r s = 0.586, p = 0.007). Lecithin cholesterol acyltransferase (LCAT) mass was negatively related with HDL 2 C, but was positively correlated with HDL 3 C and apolipoprotein A-ll. Smoking was negatively correlated with LCAT mass. Since it is believed that HDL 3 C is not associated with the risk of ischemic heart disease and since both smoking and alcohol consumption may mainly affect HDL 3 C, the current study suggests that the increase in risk of ischemic heart disease with smoking and the possible decrease with alcohol consumption may be mediated through mechanisms other than their effects on HDLC. (Arteriosclerosis 5:169-177, March/April 1985)
observation was virtually ignored until the report of Miller and Miller 2 in 1975. There is convincing epidemiologic evidence of a link between HDLC levels and diminished risk of heart disease from both prospective and prevalence studies. 34 In heterozygotes for Tangier's disease, a disorder characterized by low HDLC levels and abnormally rapid catabolism of apolipoprotein (apo) A-l, Scnaefer et al. 5 have suggested that the prevalence of heart disease is increased. Furthermore, in a patient with an absence of apo A-l and a striking reduction in HDLC, coronary artery disease was severe. 6 Many behavioral and pharmacological variables influence HDLC levels. Higher HDLC levels have been associated with female gender, 7 estrogens, 8 -10 exercise, 11 nicotinic acid, 12 and alcohol, 13 whereas lower HDLC levels have been found associated with hypertriglyceridemia, 14 obesity, 15 smoking, 16 and use of anabolic steroids. 17 -20 Many of these variables have also been associated with subsequent risk of ischemic heart disease. Alcohol has been associated with decreased risk of heart disease in some studies, 2122 but not in others. 23 Smoking has been consistently associated with increased risk of heart disease. 24 However, the situation is more complex because HDL is a heterogeneous mixture of lipoprotein particles that differ in lipid and apoprotein composition. DeLalla et al. 25 first noted that HDL was heterogeneous by using analytical ultracentrifugation. They isolated HDL, (a minor subclass), HDI_2, and HDL3. DeLalla et al. found that women had significantly higher HDLj levels than men, but similar HDL3 levels. In a prospective study published in 1966 that also used analytic ultracentrifugation, Gofman et al. 26 found that lower HDLj levels were more strongly associated with heart disease than were lower HDL, levels. Recently, Miller et al. 27 have shown that atherosclerosis as determined by coronary angiography is associated with lowered HDL.C (d = 1.063 -1.125) rather than with HDl^CCd = 1.125-1.21) levels. Ballantyne et al. 28 have shown that HDL.C, but not HDL3C, was reduced in survivors of myocardial infarction relative to control subjects.
The associations between these HDL subfractions and the factors that affect total HDL are not yet well established. The current study was designed to examine the relation between the HDL subfractions and behavioral variables such as alcohol consumption, cigarette smoking, and adiposity.
Methods

Population
All subjects were from a 2% random sample of the 5000 participants in the Pacific Northwest Bell Telephone Company Health Survey 29 conducted by the Northwest Lipid Research Clinic under the auspices of the Population Studies component of the Lipid Research Clinic Program. 30 A group of 67 individuals who were over 30 years of age at the time of initial screening (between 1972 and 1974) and who were living in the greater Seattle area were invited to participate in the present study. The study group consisted of the 33 men and 17 women (age 38 to 64 years) who gave informed consent, a response rate of 75%. The project was approved by the University of Washington Human Subjects Review Committee.
Experimental Design
The clinic visit included use of a questionnaire covering demographic information, menopausal status, medication use, smoking (number of cigarettes presently smoked), and drinking (frequency of alcohol use). Subjects were instructed to fast 12 to 14 hours before coming to the clinic where they were weighed without shoes, jackets, or coats. Height was taken with shoes removed. Body mass index (BMI) was determined by dividing weight (kg) by height squared (m 2 ).
Laboratory Methods
Blood was drawn from an antecubital vein by a 21gauge butterfly needle and put into a tube containing 1.5 mg of dry EDTA per milliliter of blood (Becton Dickinson and Company, Rutherford, New Jersey). Individuals were in a sitting position and the tourniquet was released before blood was drawn. The blood was centrifuged immediately at 1500 g for 30 minutes at 4° C, the resulting plasma was collected, and the lipoproteins and subfractions were analyzed within 72 hours. Lipoproteins were analyzed by standard Lipid Research Clinic procedures. 31 Apo A-l, A-ll, and D were measured by radial immunodiffusion. 32 -3* Lecithin cholesterol acyltransferase (LCAT) was measured by double antibody radioimmunoassay. 35 HDL subfractions were analyzed by a two-step precipitation technique. 38 Gidez et al. 36 found that the results obtained by their technique for determining HDL,C were highly correlated with the results from both analytical ultracentrifugation (n = 17, r = 0.92) and preparative ultracentrifugation (n = 295, r = 0.91). In our laboratory, blood from our population was analyzed by the Gidez precipitation method, and the results were compared with those of the analytical and preparative ultracentrifugation methods; similar results were obtained for the different techniques. 37 The correlation between the Gidez method and preparative ultracentrifugation in our laboratory (n = 49) was 0.857 for HDL.C and 0.712 for HDL3C.
A brief description of the Gidez method follows. The reagent for separating HDL was made by diluting heparin (40,000 units/ml, Riker Laboratories, Northridge, California) with 1.06 mol/L MnCI 2 at the rate of 60 ml heparin/L final volume. Then 200 fi\ of the combined heparin-Mn 2+ reagent was added to 2.0 ml of plasma at room temperature, thoroughly mixed by vortexing, and incubated 10 minutes at room temperature. After centrifugation at 1500 g for 30 minutes at 4° C, the clear HDL containing supernatant was removed with a Pasteur pipet. The reagent for HDL, separation was made by adding dextran sulfate (15,000 Daltons, Sochibo SA, Boulogne, France) to 0.15 mol/liter NaCI at the rate of 12.1 g/ liter final volume. To 1 ml of the clear supernate from the above step, 100 fx\ of the 12.1 g/liter dextran sulfate solution was added followed by thorough mixing. After incubation for 20 minutes at room temperature and centrifugation (1500 g for 30 minutes at 4°C ), the HDLj-containing supernate was collected as above. The cholesterol content of both supernates was determined by standard Lipid Research Clinic methodology 31 and corrected for the dilutions which occurred in the precipitation step. HDL.C was calculated as the difference of total HDLC and HDL3C.
Statistical Methods
The statistical analyses are based on the entire sample of men and women after insuring that the inclusion of one nonwhite female and four women who were using postmenopausal hormones did not alter the results. Descriptive statistics including the mean, standard deviation (SD), and median (50th percentile) are given separately for men and women. The Wilcoxon rank sum test statistic 38 was used to determine significant differences between men and women, and smokers and nonsmokers. Relationships between two variables were estimated using Spearman's rank correlation coefficient (r^ with a corresponding test of significance. 39 First-order Pearson correlation coefficients were used to measure the association between two variables after the linear effects of a third variable had been removed.
To obtain normal distributions, we performed logarithmic transformations on very low density lipoprotein triglyceride (VLDL-TG) and HDL,C and a square-root transformation on smoking. Caution should be used in the interpretation of probability values (p) because multiple testing increases the risk of obtaining a significant result purely by chance. In this study, the probability of detecting a true relationship between smoking and the HDL subtractions (power of a 5% significance test) is 90% if the mean difference in HDL, values between smokers and nonsmokers is 13.5 mg/dl for men and 17.7 mg/dl for women. For the HDL, subtraction, the mean differences would have to be 3.87 mg/dl and 8.17 mg/dl for men and women, respectively.
Results
Gender-specific statistics are shown in Table 1 . The groups of men and women in this study were of similar ages. The men had a higher BMI than the women. HDL-TG was significantly lower in men than in women, but the reverse was true for VLDL-TG and C. As has been shown previously, HDLC and HDL.C were significantly higher in women than in men (Table 1, Figure 1 ). Apo D was lower in women. There was no significant gender difference in the statistics for HDL3C, apo A-l, A-ll, and LCAT mass.
Spearman rank correlations between the HDL subtractions, apolipoproteins, and LCAT were performed. There was a moderately positive correlation between LCAT mass and HDLjC (men, r s = 0.478, p = 0.002; women, r s = 0.397, p = 0.058), but a negative association with HDL.C (men, r s = -0.268, p = 0.065; women, r s = -0.154, p = 0.277). LCAT mass was also moderately positively correlated with apo A-ll (men, r s = 0.374, p < 0.05; women, r s = 0.428, p < 0.05). In men, apo D was strongly positively associated with HDLjC (r s = 0.642, p < 0.001) and apo A-l (r s = 0.558, p < 0.001) and A-ll (r s --0.573, p < 0.001). Apo A-l was strongly positively correlated with both HDL,C (men, r s = 0.626, p < 0.001; women, r s = 0.469, p < 0.05) and HDL3C (men, r s = 0.635, p < 0.001; women, Spearman rank correlations between age, BMI, VLDL-TG, alcohol consumption, smoking and lipoproteins, apolipoproteins and LCAT are shown in Table 2 . There was no relationship of age with either HDLC or the cholesterol in the HDL subtractions in either men or women in this sample, but age was associated with apo D in women. BMI was positively correlated with TG in both men and women and negatively correlated with HDLC in men, but not significantly correlated in women. The negative correlation of BMI with HDL.C (men, r, = -0.335; women, r s = -0.367) was much stronger than with HDL3C (men, r s = -0.288; women r s = 0.047). The pattern of correlation between VLDL-TG and lipoproteins was similar to that between BMI and lipoproteins. VLDL-TG was significantly, negatively correlated with HDLC and more so with HDL,C in both men (r s = -0.367) and women (r s = -0.628). VLDL-TG was significantly positively correlated with LCAT mass in both genders. Alcohol was strongly positively correlated with HDLC in both men and women. Alcohol was positively related to both subclasses of HDL, although this was significant only for HDL.C in men (r s = 0.322) and strongly for HDL3C in women (r s = 0.586). Alcohol was not associated with LCAT mass in either gender. Alcohol intake was positively relat- The subjects were grouped into nonsmokers and smokers to elucidate the effect of smoking status on levels of HDL, the HDL subfractions, and LCAT mass ( Table 3 and Figures 1 and 2) . The median HDLC was significantly higher in male nonsmokers compared to smokers (46.5 vs 37.0 mg/dl, respectively). The median HDLC also was higher in female nonsmokers compared with smokers (58.5 vs 48.0 mg/dl, respectively) but this difference was not statistically significant. There was no difference between nonsmokers and smokers in HDLjC for either men or women. Both male and female smokers had signifi-cantly lower HDLjC and LCAT mass levels, and male smokers had lower apo A-I, A-ll, and D levels.
Partial correlation coefficients between HDL subfractions and cardiovascular risk factors were obtained. In this analysis, the values from both men and women were pooled, and the logarithm of HDL,C and VLDL-TG and the square root of smoking were used. The strong negative relationship between log HDL,C and log VLDL-TG (simple r = -0.596) was considerably weakened after adjustment for the linear effect of BMI (r = -0.152), which indicated that the effect of VLDL-TG on HDL.C might be partially mediated by adiposity ( Table 4 ). The simple and partial correlation coefficients between alcohol and either HDL j C or HDL3C are shown in Table 5 (Parts A and B, respectively). The correlation between alcohol intake and log HDL,C was always positive, but never statistically significant (p > 0.11). In contrast, alcohol intake and HDL,C were significantly positively correlated. The simple correlation coefficient was 0.249, the partial correlation coefficient adjusted for gender was 0.379, and adjusted for smoking was 0.221. The simple correlation coefficient between HDL3C and smoking was -0.532 (Table 6 ). When the linear effect of gender, BMI, log VLDL-TG, or alcohol use was adjusted for, there was little change in the value of the coefficient (r = -0.518 to -0.534), which suggests that the effect of smoking on HDL, is essentially independent of these other factors. Partial correlation coefficients between LCAT and smoking are given in Table 7 . The correlation coefficient between LCAT and smoking (simple r = -0.363) was not changed substantially by adjusting for gender, BMI, alcohol use, or apo D (r = -0.358 to r = -0.380), but was strengthened by log VLDL-TG (r = -0.437) and weakened by the adjustment for HDLjC (r = -0.187).
Discussion
The higher HDL and HDL,, but relatively similar HDLjC, levels in women as compared with men confirm other investigators' experience with a variety of different techniques. 253640 -* 2 The much stronger negative relation between hypertriglyceridemia and HDLjC, rather than HDLgC, has also previously been reported. 14 Similarly, BMI is more closely associated with HDL.C than with HDLjC.
The effect of alcohol consumption on heart disease mortality is still controversial, with some studies supporting a negative association 21 -a and others not confirming this relation. 23 Because alcohol consumption raises HDLC levels, 13 it has been argued that the beneficial effect of alcohol on heart disease might be due to its effect on HDLC. The present study sug- gests that while alcohol may raise both HDL.C and HDLgC levels, its major effect may be on raising HDL3C. Haskell et al. 43 have also reported that the major effect of alcohol is to raise HDL3C levels, although Taskinen et al. 44 report that both HDL,C and HDLgC fell in chronic alcoholics after alcohol withdrawal.
Smoking is a very important risk factor for ischemic heart disease. 24 It has been thought that one reason for this is smoking's effect on HDLC. Our observation that smoking is correlated with decreases in HDL3C, rather than HDL.C, is new. Since we studied a small population, it is possible that our failure to find an effect of cigarette smoking on HDL^C was due to a Type II error. Therefore, this finding needs confirmation; nevertheless, the effect of smoking was seen in both sexes and was independent of other possible confounding factors.
Smoking reportedly reduces LCAT mass. 45 Because smoking was strongly inversely correlated with LCAT mass in the current study, and since in many populations men and women have different patterns of smoking behavior, population-based estimates of LCAT mass should take into account subjects' smoking status. The negative correlation between smoking status and LCAT mass and the positive relation between LCAT mass and HDLgC in this small study suggest that LCAT action may be the mechanism for smokers' reduced levels of HDL3C. However, the LCAT action on HDL, would be expected to increase HDL particle size and reduce HDLg levels. Decreased LCAT levels, then, should increase HDL3C. At present, there is no explanation for the apparent paradox between the suggestive epidemiological data and the presumed physiological function of LCAT. Since alcohol consumption and LCAT mass are not strongly associated, the effect of alcohol consumption on raising HDLgC levels may be through a mechanism that does not require LCAT.
HDLg has generally been found to be unaffected by changes in lipoproteins, use of drugs, or behavioral variables. One exception is the effect of anabolic steroids, which reduce HDLgC (although proportionally less than the reduction in HDL.C). 20 The current study suggests that cigarette smoking and alcohol consumption principally affect the HDL,, rather than the HDL,, subfraction. Our findings are surprising, since it is felt that the protection against ischemic heart disease offered by HDL is concentrated within the HDL, subfraction. In the recent report by Criqui et al. 46 that examined data from the Lipid Research Clinic Prevalence Follow-up Study, cigarette smoking was significantly positively associated and alcohol negatively associated with cardiovascular mortality in both men and women in a Cox regression model. However, when HDL was added as an independent variable, neither the regression coefficient for cigarette smoking nor the one for alcohol intake changed appreciably, which suggests that the effect of cigarettes or alcohol on mortality was statistically independent of their effects on HDLC. Thus, the increase in heart disease risk with alcohol intake may be mediated through mechanisms independent of their effect on HDL.
